PMID- 21169832
OWN - NLM
STAT- MEDLINE
DCOM- 20110406
LR  - 20120131
IS  - 1473-6527 (Electronic)
IS  - 0951-7375 (Linking)
VI  - 24
IP  - 2
DP  - 2011 Apr
TI  - Skin infections in HIV-infected individuals in the era of HAART.
PG  - 124-9
LID - 10.1097/QCO.0b013e328342cb31 [doi]
AB  - PURPOSE OF REVIEW: Clinicians should be aware of the shift in the cutaneous 
      infectious disease burden in human immunodeficiency virus-infected individuals as 
      a reflection of immune restoration in the era of highly active antiretroviral 
      therapy (HAART). RECENT FINDINGS: As in the general population but to greater 
      extent, methicillin-resistant Staphylococcus aureus (MRSA) soft-tissue infection 
      is a rising problem among those with human immunodeficiency virus (HIV). Human 
      papilloma virus (HPV) is exceedingly prevalent and persistent despite HAART, and 
      HPV-associated malignancy is increasing as those with HIV live longer. Herpes, 
      syphilis, and Kaposi's sarcoma continue to plague individuals with HIV. Immune 
      reconstitution inflammatory syndrome (IRIS) is common and often presents with 
      infectious cutaneous manifestations. SUMMARY: This review implicates the 
      importance of the acknowledgment of MRSA infections risk factors, screening for 
      HPV-related neoplasia, continuance of trials to establish the efficacy of herpes 
      vaccines, and awareness of prevalent cutaneous infections presenting with IRIS in 
      those with HIV.
FAU - Rodgers, Sarah
AU  - Rodgers S
AD  - Department of Dermatology, Duke University Medical Center, Durham, North 
      Carolina, USA.
FAU - Leslie, Kieron S
AU  - Leslie KS
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Curr Opin Infect Dis
JT  - Current opinion in infectious diseases
JID - 8809878
SB  - IM
MH  - AIDS-Related Opportunistic Infections/chemically induced/epidemiology/*immunology
MH  - Antiretroviral Therapy, Highly Active/*adverse effects
MH  - HIV Infections/*drug therapy/immunology
MH  - Humans
MH  - Papillomavirus Infections/chemically induced/epidemiology/*immunology
MH  - Prevalence
MH  - Skin Diseases, Infectious/chemically induced/epidemiology/*immunology
EDAT- 2010/12/21 06:00
MHDA- 2011/04/07 06:00
CRDT- 2010/12/21 06:00
PHST- 2010/12/21 06:00 [entrez]
PHST- 2010/12/21 06:00 [pubmed]
PHST- 2011/04/07 06:00 [medline]
AID - 10.1097/QCO.0b013e328342cb31 [doi]
PST - ppublish
SO  - Curr Opin Infect Dis. 2011 Apr;24(2):124-9. doi: 10.1097/QCO.0b013e328342cb31.